The normal effect of feeding an antigen, such as ovalbumin (hens' egg albumin), to adult animals is the induction of a state of specific nonreactivity of the lymphoid tissues when the same antigen is presented again (oral tolerance). We have carried out feeding experiments in neonatal mice to investigate subsequent immune responses after physiologic antigen exposure and to examine the role of the neonatal intestine.
Although the usual effect of antigen exposure is induction of an active immune response, this is not always the case. Immunologic hyporesponsiveness (tolerance) may also result, and one of the most effective ways to induce this is to feed antigens (12, 26, 28, 30) . Although it has been known for over 70 yr that feeding of protein antigen to experimental animals leads to specific immunologic hyporeactivity (30) , the precise mechanisms responsible for this oral tolerance are still unclear (27) . Patients with food allergic diseases exhibit active systemic immunity to food antigens-implying that in place of oral tolerance, priming or sensitisation resulted from the feeding of antigen. The induction of similar abnormal immune responses in animals would provide a model for investigation of this group of important diseases. Because food allergic disease in humans is a feature of infancy, there is special interest in defining the mechanisms that regulate immune responses to fed antigens in neonates.
Tolerance is very readily introduced in neonatal animals when antigen is given by routes other than via the gut. This has been demonstrated with many different forms of antigen including allogeneic cells (2) , skin sensitising agents (22) , and aggregated human gammaglobulin (9) . In view of this relative ease of tolerance induction in the neonatal period, it might be expected that oral tolerance would normally be even more profound and complete in neonates than in adults. In the only report of relevant experiments, in which the antigen ovalbumin was fed to neonatal mice, however, Hanson (1 3) found priming for subsequent humoral responses, and not oral tolerance. The effects of neonatal feeding on subsequent CMI responses have not been described. We have therefore undertaken a series of experiments, to examine how the age of an animal influences specific systemic immune responses to a fed antigen, either oral tolerance or oral sensitisation (priming). Serum antibody and systemic CMI responses were studied, and the results are discussed in the context of the ontogeny of immunoregulatory T-cell functions.
MATERIALS A N D METHODS
General. Repeated oral or parenteral antigen exposure caused no ill effects, such as shock or anaphylaxis. The mortality or exclusion rate of animals fed on the first day of life was less than 4%.
The ELISA assay for serum antibodies was developed while these experiments were in progress and extensive comparisons between ELISA and passive haemagglutination technique showed a good correlation ( r = 0.949 in a group of 65 specimens) over a haemagglutination antibody titre range from one in five to one in 7680 (P < 0.001).
Feeding of antigen did not induce systemic immunity when this was tested in three separate experiments. A single feed of OVA to adult mice induced oral tolerance both for humoral antibody responses (74-92% suppression in 1 1 experiments) and for CMI (78-96% suppression in 13 experiments).
Animals. Three strains of mice were used in these experiments: BDF, (C57BL6J x DBA/2), BALB/c, and CBA. These were bred in the Animal Unit of the Western General Hospital, Edinburgh. All animals were fed Spratt's rodent diet (Spratt's Ltd, Barking, Essex, UK), which does not contain ovalbumin. Mice were weaned on to this diet at 21 d of age and were kept on a 12-h light/dark cycle with water supplied a d libitum. For defining the age of the pups, the breeding pairs were checked twice per day (9 AM, 5 PM) and litters delivered before 9 AM were assigned a birth date corresponding to the preceding day. Animals treated at d 1 were placed in experiments on the morning they were discovered and were, thus, aged between 16-24 h.
Antigens. Ovalbumin (Fraction V) and bovine serum albumin (Fraction V) were obtained from Sigma Chemical Company (Poole, Dorset, UK). These were dissolved in 0.15 M saline at a concentration of 100 mg/ml.
Intragustric administration of' antigen. Experimental animals
were not fasted. Mice aged 3 wks and more were intubated with a 19 gauge stainless steel feeding tube. Younger mice were intubated with 00 intravenous tubing (Portex Ltd, Hythe, Kent, UK) attached to a 26 gauge needle stock. In order to prevent abrasion and minimise trauma, the end of the feeding catheter was blunted by heating and checked for smoothness under a dissecting microscope. In some experiments a modified catheter with a flexible silicone rubber tip (SILASTIC, Dow Corning, USA) was used. Experimental animals which showed signs of regurgitation or bleeding after feeding were excluded. In most experiments, the intragastric dose was I mg antigen/g body weight. In experiments where dose dependence of tolerance induction was assessed, the concentration of OVA/ml was adjusted so that the maximum volume given did not exceed 0.3 ml in adult mice or 0.05 ml in neonatal mice. Control animals were given either 0.15 M saline or water by intragastric intubation.
Systemic immunisation. ) . 100 Animals were fed OVA or saline (SAL) by intragastric intubatioi~, or by intra-amniotic injection of OVA or saline, 24-36 h before birth. Four weeks later, serum was tested for antibodies, and skin tests were performed to detect CMI responses induced by this initial treatment (these tests were uniformly negative). Then, all animals were immunised with OVA in CFA parenterally and systemic antibody and CMI responses were measured by serum antibody determinations, and intradermal skin tests.
Efftlcts of intrugustric OVA administrution to neunutal, in?-mature and adult mice. lation from these data suggests that the crossover to significant tolerance induction occurs around the 10th d after birth.
Eifkcts o f OVA .feeds at d 1 on systemic immune responses in diffirmt inbred mouse strains.
In order to ensure that the observed priming effect by feeding antigen on the first day of life, was not specific for only one strain, two other strains of mice (CBA and BALB/c) were also tested. Feeding OVA on the first day of life led to qualitatively similar priming effects for both systemic antibody and CMI responses, in repeated experiments (Table 1) .
Efkcts of weaning on the induction of tolerance to OVA. By the'time mice wereaged 14 d, the magnitude of immunologic suppression by a feed of OVA was as complete as occurs in adult animals; however, this pattern was disturbed when animals were fed during the weaning period. In order to separate the effects of age and of weaning, animals were fed OVA or saline on the day of weaning, and 3 and 7 d on either side of this day. In some groups weaning was delayed for 3 d so that animals of identical age differed in their weaning date. The results are summarised in Table 2 . When mice were weaned at age 21 d, and given an OVA feed on that day, they showed no subsequent oral tolerance for antibody responses, and less than usual suppression of CMI responses. On the other hand, littermates weaned 3 d after feeding or fed OVA 3 d after weaning showed significant oral tolerance both for humoral and CMI responses. When there was an interval of 7 d between the day of weaning and OVA feed, oral tolerance analogous to that found in adult animals was observed. The transient absence of oral tolerance in these mice aged 21 d was not age related, but the result of weaning.
Influence c~fprmatal antigen exposure. The following experiments were designed to give "oral" and "parenteral" antigen in zltero, by injecting OVA into the amniotic sack (feeding) and by using intravenous injection of a pregnant female as a means of exposing the pups, systemically, to antigen. The experiments were carried out to examine whether the consistent priming, observed in animals fed antigen on the first day of life, could be increased by prenatal exposure.
lZfji;cts ofprenatal inrestinal antigen exposure. The weight of a mouse fetus on the 19th day of gestation is around 1 g. The fetuses were therefore exposed to 1 mg OVA by intra-amniotic injection of OVA in 0.05 ml volume. Results (Figs. 1 and 2, hatched bars) show that by extending the timescale of feeding experiments into uterine life, priming of the offsprings was further increased. As the amount of OVA which was, in fact, taken up by the fetus could not be exactly measured, the results are not completely comparable with the effect of closely controlled postnatal feeds. But they demonstrate clearly that antigen administration to fetuses does lead to an active priming of the immune response and that this effect extends into adult life.
Ejficts ufintravenou.~ OVA injections into pregnant,fimales on their pups' ~z~sceptihility to tolerance induction later in I@. Pregnant females were injected with OVA intravenously 24-36 h before delivery. The subsequently born pups were fed saline or OVA 4 wk after birth. All animals were then immunised with OVA in CFA and subsequent antibody and CMI responses measured as described above (Table 3 ). The results of these experiments show that intravenous OVA injection, in amounts similar to those used for intra-amniotic antigen administration, did not enhance immune reactivity in the pups. Systemic tolerance induction, produced by feeding OVA at the age of 28 d, was identical in the pups of saline-and OVA-injected mothers.
Specificity of priming by intra-amniotic antigen injection.
Priming for OVA responses was shown to be antigen-specific, because intra-amniotic administration of bovine serum albumin did not lead to enhancement of anti-OVA immune responses.
Attempt to tolerise neonatally primed animuls hyfurther oral antigen administration. A series of experiments were performed, in order to determine whether it is possible to modulate subsequent immune responses in animals given a priming dose of OVA in the neonatal period. Further feeds of OVA were given to the animals, either in the first few days of life or in young adult life. Theoretically, these could lead to increase in the priming effect or to the subsequent recreation of oral tolerance. It was particularly important to examine whether primed animals could be retolerised by one or more feeding regimens which extended into the period where young animals are usually tolerisable (by age 14 d).
Effects oj'age, frequency, and total amounts of neonatal OVA .feeds on .subsequent immune responses. The different feeding schedules and antigen doses are summarised in Table 4 . Animals were fed OVA or saline on the first day of life and 4 or 14 d thereafter. Two groups of animals were fed daily for 4 and 14 d. The effect of antigen dose was examined by feeding the total amount which had been given to these groups of animals over 4 or 14 d, in a single dose on the 4th or 14th d of life. Sham-fed control groups were incorporated into these experiments.
For simplicity, the groups have been identified A to G (see Table 4 ). Group A (one day 1 feed) demonstrates that the priming effect of a single OVA feed is still detectable after 2 wk, and Group B (two feeds; d 1, 14) shows that a single refeed does not reverse this effect. But the group of mice fed daily for the first 4 d of life (Group C, four daily feeds) showed suppression of their antibody responses (P < 0.001) and reduced although not significantly suppressed CMI response (P < 0.1). In contrast mice receiving an identical total quantity of OVA in a single dose on the 4th d of life (Group D, one feed d 4) showed no suppression OVA on the first day of life and attempts were made to retolerise these mice by an OVA feed 2, 4,6, 10, and 14 wk after the initial treatment. The results are illustrated in Figure 3 . Primed antibody responses were found to be partially suppressable by an OVA feed only 2 wk after the initial priming dose and they were indistinguishable from those of tolerant animals when retolerisation was performed 4 wk after the initial treatment. On the other hand, CMI responses exhibited a striking disparity and retolerisation was not accomplished before 14 wk. Pc~r.si.rtence of priming in unima1.s that received intra-amniotic OVA und were refed OVA at age 28 d. OVA or saline was administered intra-amniotically by injection 24-36 h before birth, and the pups were subsequently fed OVA or saline at age 28 d. Results in the intra-amniotic saline group show that this manipulation had no effect on the capacity of the pups to respond in a normal manner (by oral tolerance) when OVA was first administered by feeding at age 28 d. On the other hand, animals that had been exposed to ovalbumin by intra-amniotic injection demonstrated oral tolerance for serum antibody responses when retolerisation was attempted by feeding OVA 4 wk after birth, whereas tolerance for CMI responses was not present in the same animals ( Table 5 ). These experiments demonstrate that prenatal antigen exposure had similar effects on subsequent immune responses as did feeding on the first day of life (Fig. 3) .
DISCUSSION
Whereas feeding of a weight-related dose of OVA to adult mice consistently produces tolerance (12, 26, 28) , we have demonstrated in this study that when an equivalent dose is fed to neonatal mice within the first week of life, oral tolerance does not occur. Furthermore, animals fed on d 1 of life were primed, and when fetuses were exposed to antigen via intra-amniotic administration, an even greater priming of subsequent systemic immune responses occurred. These results confirm and extend the previous report (13) that a feed of OVA to mice on the first day of life primes for subsequent antibody responses. We attempted to modulate or reverse this priming phenomenon in two ways: by a retolerisation feed and by varying the antigen dose and frequency. The priming effects persist for several weeks but it proved possible to create a state of tolerance for systemic antibody responses by another tolerising feed 4 wk after the neonatal feed; for CMI, however, the state of non-tolerance persisted for 14 wk. In addition, we demonstrated that several daily doses of antigen (starting on d 1) induced tolerance whereas the same total dose fed on a single occasion did not.
Failure to induce tolerance by an important physiologic route of antigen exposure is in striking contrast to the generally recognised pattern that neonatal mice are very readily tolerised by antigen given by other routes (2, 5, 9) . It has been reported that a feed of human gammaglobulin tolerises neonatal mice, in contrast to the priming effect of feeding OVA ( 1 3) and this was interpreted by Hanson to be a dose-related phenomenon. Human gammaglobulin is, however, an atypical substance to use as an antigen for investigating immune responses to dietery antigens because of its preferential absorption and handling by the neonatal gut (3, 17) . body responses in the neonate is due to direct effects of antigen E on B cells. But because we showed systemic CMI effects too, there must also be direct or indirect T cell involvement.
The immunologic effects of feeding in the neonatal period s may, however, be unrelated to the state of maturity of the lymphoid system. It is equally possible that immaturity of the neonatal digestive and absorptive functions is the key factor (4). The permeability of the neonatal gut to macromolecules is increased, as, for example, demonstrated by high concentrations of serum antigen after feeding (8, 29) . Although the quantity of a circulating antigen may be important, the immunochemical properties and characteristics of absorbed antigen may be equally as relevant. We found that gut-processed fragments of OVA circulate in the serum 60 min after feeding of OVA to adult \ .
-C % S mice, and that these can induce tolerance for CMI in adult 8 2 7
.-e 2 recipients of such serum (25) . But it has also been shown that in 4, quent systemic immune responses at the cellular level (24) . This should be directed towards the documentation of development of the mucosal immune system, both with respect to immunoregulatory and effector functions. It will always also be essential to examine the immunochemical properties of immunogenic materials which are found in blood after enteral administration. Our experiments have addressed only those antibody responses detected by passive haemagglutination and ELISA techniques, as well as CMI. Subsequent work should also concern the effects of neonatal antigen exposure on IgE antibodies. Nevertheless, the work described above should provide a structured basis for investigation of an important clinical problem: that feeding protein antigens to human neonates at a time when both digestive and immune systems are immature sometimes sensitises the infant for potentially harmful immune responses to foods, and thereby food allergic diseases.
= 25) were 36-77% higher than in matched controls depending on age of cell culture (9.0-10.6 versus 5.1-7.8 nmol/mg cellular protein). Cellular Ca" was significantly elevated in CF, but was not a reliable criterion for identifying C F cells because of the high variability of results. Studies of Ca2+ fluxes in cell organelles showed that mitochondria isolated from C F fibroblasts accumu- I n vitro experiments showed that Ca2+ influx and efflux are increased in isolated C F mitochondria, resulting in net Ca2+ accumulation. Ca2+ uptake in mitochondria is energy-dependent; some inhibitors of mitochondrial energy metabolism (atractyloside, oligomycin) influenced Ca2+ uptake significantly more in C F than in control mitochondria. Furthermore, the average activities of NADH oxidase, NADH-and succinate-cytochrome c reductase were 77, 58, and 48% higher in C F mitochondria, respectively. This indicates that many functions associated with energy metabolism and the mitochondrial membrane (electron transport, ATP transport, and ATP hydrolysis) are not operating properly in CF, thus possibly causing the derangement of Ca2+ metabolism found in C F mitochondria and cells.
Abbreviation CF, cystic fibrosis
An interesting feature of C F research is the multiformity of results reported in the litcrature (8. 33, 34) . Only recently, studies of the Vatican records on dispensations for cousin-cousin marriages have confirmed that C F is a tnono,qmic. autosomal recessive disease with an incidence of up to 1 in 1600 in some Caucasian populations (i.c., northern Europe) (9) . Because only a single gene must account for all the phenomenons of CF, it Vol. 18, No. 7, 1984 Prinred in U. S. A.
seems reasonable to conceive a working model which would explain this heterogenous exocrinopathy that still is the most common lethal genetic disease in Europe and the United States (8. 35). C F must surely involve some basic event of cellular function or the diversity of reported results is hardly comprehensible. The emphasis of our studies was put on Ca" metabolism which has been suggested to be central in the pathogenesis of CF by various authors (2, 3. 16, 18, 28) . Ca", an intracellular messenger, is linked to many cellular functions (c.g., secretion, protein phosphorylation and activation. and protein synthesis: for a recent review see ref. 7) . A derangement, therefore, of cellular Ca" can cause a variety of different phenomenons, making it a possible candidate for explaining the manifold features reported in CF.
Our study's first aim was to quantify elevated intracellular Ca" in C F and see if it is possible to establish a simple and reliable test to discriminate between CF and control cells on this basis. Second, Ca" metabolism was studied in cell organelles (mitochondria. endoplasmic reticulum) that account for 95-98% of intracellular Ca" and presumably must be affected if intracellular Ca2+ is significantly altered. Our investigations centered on the energy-dependent Ca2+ uptake and Ca" efflux in mitochondria which showed to be definitely altered in C F cells. By employing different inhibitors of mitochondrial Ca" uptake, ATP transport, ATP hydrolysis and electron transfer, and by measuring electron transfer activities directly, changes in mitochondrial Ca" and energy metabolism could be detected in CF. The surnestion of a mitochondrial focus in CF. first made bv Feigal z d Shapiro. was confirmed ( 1 1, 28) . 
